SITAGLIVAC 25

SITAGLIVAC 25 contains Sitagliptin 25 mg, an oral antidiabetic medicine that belongs to the class of DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors). It is used to treat Type 2 Diabetes Mellitus (T2DM) by helping the body increase insulin production and reduce excess glucose release from the liver.

When combined with a healthy diet and regular exercise, SITAGLIVAC 25 helps in maintaining optimal blood sugar levels and reducing the risk of diabetes-related complications.

Key Benefits:

• Improves glycemic control in adults with Type 2 Diabetes

• Enhances natural insulin production after meals

• Reduces excessive glucose release from the liver

• Can be used alone or in combination with other antidiabetic medicines (like Metformin or Sulfonylureas)

• Low risk of hypoglycemia compared to other agents